All News

Despite scant research regarding medical use of cannabis, strong popular sentiment is driving legalization of the flowering plant for therapeutic use.

The Food and Drug Administration has approved the combination regimen of Revlimid plus Rituxan for use in patients with previously-treated follicular lymphoma and marginal zone lymphoma.

On those dark days, cancer survivors need to remember there are rays of sunshine behind the clouds.

As a cancer survivor and advocate, I have gotten the calls that we survivors hate: calls from someone we don’t know who says that a mutual friend told them to call, and friends saying they have been received a diagnosis. I am always ready when the phone rings.

We have to find light in the darkness of cancer not just for ourselves, but for those that will come after us.

Exercises specifically designed for breast cancer survivors are helpful after surgery and years out, if we remember to do them!

The Food and Drug Administration has approved the PI3K inhibitor Piqray (alpelisib) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast cancer following progression on or after an endocrine-based regimen.

The FDA has approved Jakafi, the first and only treatment of steroid-refractory acute graft-versus-host disease in adult and pediatric patients aged 12 years and older.

From World Blood Cancer Day to today’s top performers fundraising for lifesaving research, here’s what’s making headlines in the cancer space this week.

With greater longevity for survivors of melanoma comes the need to treat lingering side effects and monitor for cancer recurrences.

When you are lost you ask, "Where am I?" When you go through cancer, it is hard to find where you are. In the map of life, why not find yourself where you are in this very moment? You are here.

The Food and Drug Administration has approved the NovoTTF-100L System in combination with pemetrexed and platinum-based chemotherapy for the front-line treatment of patients with unresectable, locally advanced or metastatic malignant pleural mesothelioma.

Four out of 100. That is the survival rate for stage 4 glioblastoma: four percent.

Learn about awareness and actions strategies during Brain Tumor Awareness Month and beyond.

Two oncology dietitians weigh in on the results of a recent study that show a low-fat diet rich in fruits, vegetables and grains can reduce the risk of dying from breast cancer.

In this issue of CURE®, we tackle the controversial topic of medical cannabis.

Funds raised by the V Foundation for Cancer Research’s Victory Ride to Cure Cancer benefit cancer research in North Carolina and beyond.

As a result of what I went through and my never-ending passion for helping others, I believe that my diagnosis happened for a reason – to lead me to a career in patient advocacy.

How long would it take you to pack if someone from emergency preparedness were to knock on your door and say you have 24 hours or less to be ready to leave your home with no certainty it might still be livable when you return?

Patients with advanced renal cell carcinoma have new first-line therapy options.

Thousands of men who will be diagnosed with prostate cancer this year alone now have a wealth of new and updated resources to ensure they make the best treatment choices they can.

Precision medicine has prolonged life for many with lung cancer, giving them opportunities to support those who are newly diagnosed.

The power of friendship within the world of metastatic cancer has hit home for this survivor.

$600,000 grant awarded over three years at Boston Children’s Hospital.

A two-time cancer survivor finds cancer worries a little easier to face with time and experience.

Compared with the general population, men and women with type 2 diabetes face greater risk of developing certain cancers, such as colorectal, kidney, liver and more.

We've got a sneak peek at what’s inside Heal®'s spring issue.

Breakfast, lunch and dinner options that require minimal prep work and time.

One of the hardest things to realize about cancer is that it rarely goes in a straight line.

While many advances have been made in the treatment landscape of MCL, the need for curative treatment options may be where future research goes.